The Global Health Challenge

Manila Bulletin, November 22, 2010 | Go to article overview

The Global Health Challenge

Access to healthcare has been one of the world's most pressing social challenges today. Each year, millions of people in developing countries die from curable infectious diseases because they do not have access to basic healthcare each day. More than two million children still die each year from vaccine-preventable diseases. It is a complex problem with no simple solution. Facing such difficulties, GlaxoSmithKline (GSK) recently held its annual media day to discuss issues and its response to other health priority areas in the region.Present during the event were three keynote speakers headed by Christophe Weber, senior vice president and and regional director of GSK in Asia Pacific. Weber shared his views on access to medicines as a global health challenge and how GSK's innovative approach to access in the region has a vital role to play. On the other hand, a respiratory medicine specialist from Hong Kong, Dr. Roland Leung, presented the disease burden of asthma and treatment priorities while Dr. Michael Elliott, vice president and area medical director of GSK Australia and Asia Pacific shared news of GSK's efforts to combat malaria, tubercolosis (TB), and human immunodeficiency virus / acquired immune deficiency syndrome (HIV-AIDS) which have particular impact in Asia.Limited access"We know it's a challenge and we know that there are a lot to do," discloses Weber. He adds, "It is a complex and multifaceted problem with no simple solution, though poverty reduction is vital."Weber cites diversity and complexity of developing Asia, weak health infrastructure, medicine affordability to patients, and the pharma industry's research and development-based business model as key factors contributing to the global challenge. "We are also part of the problem but we are trained to find solutions and that's what we are doing."Access to medicine is about improving healthcare and it's a global dilemma marked by a few indicators. One of which is looking at the data provided by the World Health Organization (WHO) describing infant and maternal mortality ratio. As indicated, millions of children die from infectious diseases which could be prevented. While immunization coverage in Asia Pacific varies, Hib3 remains the least utilized vaccine with no coverage in the Western Pacific region and 36 percent globally. Meanwhile, utilization of DTP3, MCV, HepB3. and Hib3 are 80 to 90 percent for Southeast Asia."Basically, if you want to reach a good level of coverage, it should be at least 80 percent covered, otherwise, the population is at risk," Weber warns adding that, "That situation is not correlated with the economic development of the country, it is correlated to the vaccine-policy by the country. There is an access issue in medicines and that access issue is not always perceived by the population."Weber even went as far as using the country as an example. "If you look at vaccination policy, Asia Pacific is really behind, Philippines as well. It's extremely at the beginning... either they get old vaccines or inefficient vaccines."He further explains, "Some vaccines have individual benefits but also some population benefit. If you vaccinate everybody, you eradicate the disease but for that you need a high coverage. And for that, you need a policy to allow access to even the poorest of the population. If you have no policy and certain portion of the population cannot afford you will never eradicate the disease."Diseases of the developing worldMeanwhile, Dr. Michael Elliott discussed GSK's activities concerning diseases that predominate developing world such as TB, Malaria, and HIV-AIDS which kills 20,000 people each day. It has become a global health crisis especially for the poorest countries."The WHO identified the crisis with these three tropical diseases. That's a huge burden on patients, on healthcare systems, and on the economy of those countries. Without the infrastracture in health care or the access to medicine, no one will be able to succeed in addressing that great burden," says ElliottBy the numbers, there are 33 million people across the world living with HIV, 250 million cases of malaria, and 9. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Cite this article

Cited article

Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25,

Note: primary sources have slightly different requirements for citation. Please see these guidelines for more information.

Cited article

The Global Health Challenge


Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25,

    New feature

    It is estimated that 1 in 10 people have dyslexia, and in an effort to make Questia easier to use for those people, we have added a new choice of font to the Reader. That font is called OpenDyslexic, and has been designed to help with some of the symptoms of dyslexia. For more information on this font, please visit

    To use OpenDyslexic, choose it from the Typeface list in Font settings.

    OK, got it!

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Author Advanced search


    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.